Kni 102
| Code | Size | Price |
|---|
| TAR-T32407-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Kni 102 is a biochemical.
CAS:
139694-65-8
Formula:
C31H41N5O7
Molecular Weight:
595.697
Purity:
0.98
SMILES:
CC(C)(C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)OCc1ccccc1
References
1. Asagarasu A, Takayanagi N, Achiwa K. Synthesis of dipeptide-type human immunodeficiency virus (HIV) protease inhibitors with a binding unit to gp120. Chem Pharm Bull (Tokyo). 1998 May;46(5):867-70. PubMed PMID: 9621421.
2. Asagarasu A, Uchiyama T, Achiwa K. Syntheses of HIV-protease inhibitors having a peptide moiety which binds to GP120. Chem Pharm Bull (Tokyo). 1998 Apr;46(4):697-703. PubMed PMID: 9579045.
3. Marastoni M, Fantin G, Bortolotti F, Tomatis R. Synthesis and activity of pseudotripeptide inhibitors of HIV-1 protease containing D(-)-O-(benzyl)tartaric acid. Arzneimittelforschung. 1996 Nov;46(11):1099-101. PubMed PMID: 8955873.
4. el-Farrash MA, Kuroda MJ, Kitazaki T, Masuda T, Kato K, Hatanaka M, Harada S. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor. J Virol. 1994 Jan;68(1):233-9. PubMed PMID: 8254733; PubMed Central PMCID: PMC236282.